Antiinflammatory therapy with canakinumab for atherosclerotic disease

Ridker, P. M. et al. (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. New England Journal of Medicine, 377(12), pp. 1119-1131. (doi: 10.1056/NEJMoa1707914) (PMID:28845751)

210333.pdf - Published Version



No abstract available.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Sattar, Professor Naveed
Authors: Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., Kastelein, J. J.P., Cornel, J. H., Pais, P., Pella, D., Genest, J., Cifkova, R., Lorenzatti, A., Forster, T., Kobalava, Z., Vida-Simiti, L., Flather, M., Shimokawa, H., Ogawa, H., Dellborg, M., Rossi, P. R.F., Troquay, R. P.T., Libby, P., Glynn, R. J., and CANTOS Trial Group,
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:New England Journal of Medicine
Publisher:Massachusetts Medical Society
ISSN (Online):1533-4406
Published Online:17 August 2017
Copyright Holders:Copyright © 2017 Massachusetts Medical Society
First Published:First published in New England Journal of Medicine 377(12):1119-1131
Publisher Policy:Reproduced in accordance with the copyright policy of the publisher

University Staff: Request a correction | Enlighten Editors: Update this record